Lataa...
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
The combination of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, with an acetylcholinesterase inhibitor (AChEI) is the current standard of care in Alzheimer's disease (AD). Galantamine, an AChEI currently marketed for the treatment of AD, exerts memory-enhancing and neuroprotec...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607148/ https://ncbi.nlm.nih.gov/pubmed/23532860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.118 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|